Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. 110學年度
  5. 酪蛋白激酶 CK1 在多型性神經膠質母細胞瘤的角色及其抑制劑之藥理機制探討
 
  • Details
Options

酪蛋白激酶 CK1 在多型性神經膠質母細胞瘤的角色及其抑制劑之藥理機制探討

Other Title
The Pharmacological Role of Casein Kinase 1 and Its Inhibitors on Glioblastoma Cells
Type
thesis
Date Issued
2022-01-14
Author(s)
蕭敬衡
Advisor
潘秀玲
Subjects
系所名稱:癌症生物學與藥物研發研究所碩士班
Publisher
癌症生物學與藥物研發研究所碩士班
Description
口試委員:許凱程 HSU, KAI-CHENG;潘秀玲 PAN, SHIOW-LIN;皇甫維君 HUANGFU, WEI-CHUN
網際網路,開放日期為2024-02-28
URI
https://handle.ncl.edu.tw/11296/rk8t33
https://203.71.86.71/handle/123456789/10477

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback